Drug Shortage Report for SEVOFLURANE

Last updated on 2024-10-23 History
Report ID 236909
Drug Identification Number 02265974
Brand name SEVOFLURANE
Common or Proper name SEVOFLURANE
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) SEVOFLURANE
Strength(s) 99.97%
Dosage form(s) LIQUID
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 250 mL
ATC code N01AB
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-09-06
Actual start date 2024-09-06
Estimated end date 2024-10-22
Actual end date 2024-10-22
Shortage status Resolved
Updated date 2024-10-23
Company comments For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative. CA2L9117SV (Fused Bottle with integrated Safe-T-Seal Adaptor) is available as an alternative.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-10-23 English Compare
v5 2024-10-22 French Compare
v4 2024-10-22 English Compare
v3 2024-09-07 English Compare
v2 2024-09-06 French Compare
v1 2024-09-06 English Compare

Showing 1 to 6 of 6